Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne M Stanford

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Trends in Immunology|June 1, 2005
The 'supervirus'? Lessons from IL-4-expressing poxvirusesMarianne M Stanford, Grant McFadden
Expert Opinion on Biological Therapy|August 31, 2007
Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancerMarianne M Stanford, Grant McFadden
Journal of Leukocyte Biology|September 10, 2003
The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivoMarianne M Stanford, Thomas B Issekutz
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Delineation of five thyroglobulin T cell epitopes with pathogenic potential in experimental autoimmune thyroiditisPanayotis Verginis, Marianne M Stanford, George Carayanniotis
Veterinary Research|February 14, 2007
Myxoma virus in the European rabbit: interactions between the virus and its susceptible hostMarianne M Stanford, Steven J Werden, Grant McFadden
Immunology and Cell Biology|January 18, 2007
Immunopathogenesis of poxvirus infections: forecasting the impending stormMarianne M Stanford, Grant McFadden, Gunasegaran Karupiah, et al.
Current Opinion in Molecular Therapeutics|January 30, 2008
Innate immunity, tumor microenvironment and oncolytic virus therapy: friends or foes?Marianne M Stanford, Caroline J Breitbach, John C Bell, et al.
Cytokine & Growth Factor Reviews|March 12, 2010
Novel oncolytic viruses: riding high on the next wave?Marianne M Stanford, John C Bell, Markus J V Vähä-Koskela
Scientific Reports|February 25, 2021
Combination of a T cell activating therapy and anti-phosphatidylserine enhances anti-tumour immune responses in a HPV16 E7-expressing C3 tumour modelBrennan S Dirk, Genevieve Weir, Tara Quinton, et al.
Journal of Virology|August 31, 2007
Myxoma virus expressing human interleukin-12 does not induce myxomatosis in European rabbitsMarianne M Stanford, John W Barrett, Philippe-Alexandre Gilbert, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Trends in Immunology|June 1, 2005
The 'supervirus'? Lessons from IL-4-expressing poxvirusesMarianne M Stanford, Grant McFadden
Expert Opinion on Biological Therapy|August 31, 2007
Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancerMarianne M Stanford, Grant McFadden
Journal of Leukocyte Biology|September 10, 2003
The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivoMarianne M Stanford, Thomas B Issekutz
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Delineation of five thyroglobulin T cell epitopes with pathogenic potential in experimental autoimmune thyroiditisPanayotis Verginis, Marianne M Stanford, George Carayanniotis
Veterinary Research|February 14, 2007
Myxoma virus in the European rabbit: interactions between the virus and its susceptible hostMarianne M Stanford, Steven J Werden, Grant McFadden
Immunology and Cell Biology|January 18, 2007
Immunopathogenesis of poxvirus infections: forecasting the impending stormMarianne M Stanford, Grant McFadden, Gunasegaran Karupiah, et al.
Current Opinion in Molecular Therapeutics|January 30, 2008
Innate immunity, tumor microenvironment and oncolytic virus therapy: friends or foes?Marianne M Stanford, Caroline J Breitbach, John C Bell, et al.
Cytokine & Growth Factor Reviews|March 12, 2010
Novel oncolytic viruses: riding high on the next wave?Marianne M Stanford, John C Bell, Markus J V Vähä-Koskela
Scientific Reports|February 25, 2021
Combination of a T cell activating therapy and anti-phosphatidylserine enhances anti-tumour immune responses in a HPV16 E7-expressing C3 tumour modelBrennan S Dirk, Genevieve Weir, Tara Quinton, et al.
Journal of Virology|August 31, 2007
Myxoma virus expressing human interleukin-12 does not induce myxomatosis in European rabbitsMarianne M Stanford, John W Barrett, Philippe-Alexandre Gilbert, et al.
Pageof 4